Trisha Bartlett, PA
Medical · Webster City, IANPI 1245457977
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 41.3% of the total.
Across 67 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$615
- Johnson & Johnson$350
- UCB, Inc.$136
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$67
- Amgen$65
- Pfizer$65
- plus $193 from 7 others
What the payments were for
- Food & beverage$87158%
- Education$62042%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 35 | $615 |
| Johnson & Johnson | 8 | $350 |
| UCB, Inc. | 7 | $136 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $67 |
| Amgen | 3 | $65 |
| Pfizer | 3 | $65 |
| Novartis | 3 | $60 |
| Janssen Scientific Affairs, LLC | 1 | $33 |
| AbbVie | 1 | $24 |
| Sanofi | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Organon | 2 | $17 |
| Dermavant Sciences, Inc. | 1 | $16 |
How this compares
$1,491 in reported general payments places this provider in the 75th percentile of 141 medical providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $87,879 |
| Dupixent PenDupilumab | 12 | $42,820 |
| Ketoconazole | 113 | $4,358 |
| Fluorouracil | 21 | $2,076 |
| Clobetasol Propionate | 16 | $1,130 |
| Metronidazole | 11 | $924 |
| ValacyclovirValacyclovir Hcl | 15 | $284 |
| Triamcinolone Acetonide | 43 | $271 |
| Minocycline Hcl | 11 | $173 |
| Mupirocin | 16 | $90 |
| Cephalexin | 15 | $37 |
| Amoxicillin | 34 | $27 |
Paid to pharmacies, not to this prescriber.
Other medical in Webster City
- Patricia ArasonWest Des Moines$119K
- Maria SonnackIowa City$100K
- Kristin BabbAtlantic$16K
- Laura QuinnetteCouncil Bluffs$14K
- Laurie HughellUrbandale$9K
- Elizabeth McCullochWest Des Moines$6K
- Jordan GreinerPella$6K
- Samantha SmithBrooklyn$5K
- Emily EricksonDes Moines$5K
- Jennifer VandivierWest Des Moines$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.